Cutera, Inc. (CUTR)
USD 0.1
(0.0%)
USD 0.1
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -156.23 Million USD | -309.09% |
| 2022 | -38.19 Million USD | -2869.67% |
| 2021 | -1.28 Million USD | 94.37% |
| 2020 | -22.82 Million USD | -89.22% |
| 2019 | -12.06 Million USD | 9.92% |
| 2018 | -13.39 Million USD | -220.91% |
| 2017 | 11.07 Million USD | 362.08% |
| 2016 | 2.39 Million USD | 153.02% |
| 2015 | -4.52 Million USD | 57.43% |
| 2014 | -10.61 Million USD | -102.04% |
| 2013 | -5.25 Million USD | 23.01% |
| 2012 | -6.82 Million USD | 34.56% |
| 2011 | -10.43 Million USD | 6.01% |
| 2010 | -11.09 Million USD | -7.31% |
| 2009 | -10.34 Million USD | -228.04% |
| 2008 | -3.15 Million USD | -132.99% |
| 2007 | 9.55 Million USD | 459.69% |
| 2006 | -2.65 Million USD | -115.94% |
| 2005 | 16.67 Million USD | 223.54% |
| 2004 | 5.15 Million USD | -0.21% |
| 2003 | 5.16 Million USD | 288.27% |
| 2002 | 1.33 Million USD | -47.01% |
| 2001 | 2.51 Million USD | 197.39% |
| 2000 | 844 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -29.14 Million USD | 34.24% |
| 2024 Q2 | -21.8 Million USD | 25.18% |
| 2023 FY | -156.23 Million USD | -309.09% |
| 2023 Q3 | -40.94 Million USD | -38.67% |
| 2023 Q1 | -23.56 Million USD | -325.74% |
| 2023 Q2 | -29.52 Million USD | -25.29% |
| 2023 Q4 | -44.31 Million USD | -8.23% |
| 2022 Q4 | -5.53 Million USD | 41.31% |
| 2022 FY | -38.19 Million USD | -2869.67% |
| 2022 Q1 | -13.15 Million USD | -548.45% |
| 2022 Q2 | -10.06 Million USD | 23.51% |
| 2022 Q3 | -9.43 Million USD | 6.27% |
| 2021 Q1 | 1.16 Million USD | -19.27% |
| 2021 FY | -1.28 Million USD | 94.37% |
| 2021 Q3 | 626 Thousand USD | -69.73% |
| 2021 Q4 | -2.02 Million USD | -424.12% |
| 2021 Q2 | 2.06 Million USD | 77.51% |
| 2020 FY | -22.82 Million USD | -89.22% |
| 2020 Q1 | -12.12 Million USD | -528.77% |
| 2020 Q2 | -10.93 Million USD | 9.88% |
| 2020 Q4 | 1.44 Million USD | 219.16% |
| 2020 Q3 | -1.21 Million USD | 88.92% |
| 2019 Q2 | 299 Thousand USD | 103.73% |
| 2019 Q1 | -8.02 Million USD | -46.19% |
| 2019 Q4 | -1.92 Million USD | 19.93% |
| 2019 Q3 | -2.4 Million USD | -905.69% |
| 2019 FY | -12.06 Million USD | 9.92% |
| 2018 Q3 | -998 Thousand USD | 53.69% |
| 2018 Q1 | -4.74 Million USD | -204.53% |
| 2018 Q2 | -2.15 Million USD | 54.62% |
| 2018 FY | -13.39 Million USD | -220.91% |
| 2018 Q4 | -5.49 Million USD | -450.1% |
| 2017 Q2 | 1.73 Million USD | 222.43% |
| 2017 Q4 | 4.54 Million USD | -26.91% |
| 2017 Q3 | 6.21 Million USD | 259.31% |
| 2017 FY | 11.07 Million USD | 362.08% |
| 2017 Q1 | -1.41 Million USD | -131.79% |
| 2016 Q1 | -2.17 Million USD | -208.71% |
| 2016 Q2 | -1.41 Million USD | 34.78% |
| 2016 Q4 | 4.44 Million USD | 188.82% |
| 2016 Q3 | 1.53 Million USD | 208.69% |
| 2016 FY | 2.39 Million USD | 153.02% |
| 2015 Q4 | 1.99 Million USD | 302.95% |
| 2015 FY | -4.52 Million USD | 57.43% |
| 2015 Q3 | -984 Thousand USD | 49.07% |
| 2015 Q2 | -1.93 Million USD | 46.36% |
| 2015 Q1 | -3.6 Million USD | -126.26% |
| 2014 Q1 | -3.65 Million USD | -974.41% |
| 2014 Q2 | -2.83 Million USD | 22.39% |
| 2014 Q3 | -2.53 Million USD | 10.44% |
| 2014 Q4 | -1.59 Million USD | 37.3% |
| 2014 FY | -10.61 Million USD | -102.04% |
| 2013 Q1 | -2.31 Million USD | -316.85% |
| 2013 FY | -5.25 Million USD | 23.01% |
| 2013 Q4 | -340 Thousand USD | 82.8% |
| 2013 Q3 | -1.97 Million USD | -217.34% |
| 2013 Q2 | -623 Thousand USD | 73.1% |
| 2012 Q3 | -1.1 Million USD | 27.15% |
| 2012 FY | -6.82 Million USD | 34.56% |
| 2012 Q1 | -5.26 Million USD | -463.81% |
| 2012 Q2 | -1.52 Million USD | 71.12% |
| 2012 Q4 | 1.06 Million USD | 196.39% |
| 2011 Q3 | -2.62 Million USD | 8.21% |
| 2011 Q2 | -2.86 Million USD | 28.55% |
| 2011 Q1 | -4 Million USD | -158.35% |
| 2011 FY | -10.43 Million USD | 6.01% |
| 2011 Q4 | -934 Thousand USD | 64.46% |
| 2010 Q4 | -1.55 Million USD | 56.81% |
| 2010 FY | -11.09 Million USD | -7.31% |
| 2010 Q1 | -2.13 Million USD | -411.24% |
| 2010 Q2 | -3.82 Million USD | -78.76% |
| 2010 Q3 | -3.59 Million USD | 5.99% |
| 2009 Q1 | -3.62 Million USD | -873.66% |
| 2009 Q2 | -4.64 Million USD | -28.3% |
| 2009 Q4 | -418 Thousand USD | 74.76% |
| 2009 Q3 | -1.65 Million USD | 64.36% |
| 2009 FY | -10.34 Million USD | -228.04% |
| 2008 Q1 | -1.67 Million USD | -158.77% |
| 2008 Q3 | -1.2 Million USD | -1363.16% |
| 2008 Q4 | -372 Thousand USD | 69.0% |
| 2008 FY | -3.15 Million USD | -132.99% |
| 2008 Q2 | 95 Thousand USD | 105.67% |
| 2007 Q3 | 3.1 Million USD | 59.38% |
| 2007 Q4 | 2.85 Million USD | -8.24% |
| 2007 FY | 9.55 Million USD | 459.69% |
| 2007 Q1 | 1.64 Million USD | -81.18% |
| 2007 Q2 | 1.95 Million USD | 18.33% |
| 2006 Q1 | 718 Thousand USD | -89.67% |
| 2006 Q4 | 8.75 Million USD | 134.15% |
| 2006 Q3 | 3.73 Million USD | 123.56% |
| 2006 Q2 | -15.86 Million USD | -2310.17% |
| 2006 FY | -2.65 Million USD | -115.94% |
| 2005 FY | 16.67 Million USD | 223.54% |
| 2005 Q4 | 6.95 Million USD | 47.16% |
| 2005 Q3 | 4.72 Million USD | 49.49% |
| 2005 Q2 | 3.16 Million USD | 72.11% |
| 2005 Q1 | 1.83 Million USD | -32.67% |
| 2004 FY | 5.15 Million USD | -0.21% |
| 2004 Q3 | 1.15 Million USD | 18.66% |
| 2004 Q1 | 305 Thousand USD | -86.72% |
| 2004 Q2 | 970 Thousand USD | 218.03% |
| 2004 Q4 | 2.72 Million USD | 136.92% |
| 2003 Q4 | 2.29 Million USD | 23.91% |
| 2003 Q2 | 1.15 Million USD | 0.0% |
| 2003 FY | 5.16 Million USD | 288.27% |
| 2003 Q3 | 1.85 Million USD | 60.99% |
| 2002 FY | 1.33 Million USD | -47.01% |
| 2001 FY | 2.51 Million USD | 197.39% |
| 2000 FY | 844 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | -987.877% |
| Cerus Corporation | -30.05 Million USD | -419.848% |
| OrthoPediatrics Corp. | -25.76 Million USD | -506.342% |
| PetVivo Holdings, Inc. | -10.62 Million USD | -1370.907% |
| Talis Biomedical Corporation | -66.81 Million USD | -133.825% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | -803.272% |
| Inogen, Inc. | -109.38 Million USD | -42.824% |
| Spectral AI, Inc. | -12.98 Million USD | -1103.25% |
| Nano-X Imaging Ltd. | -62.58 Million USD | -149.613% |
| CVRx, Inc. | -43.1 Million USD | -262.457% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -4328.288% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | -1157.081% |
| Orthofix Medical Inc. | -139.11 Million USD | -12.307% |
| Venus Concept Inc. | -28.3 Million USD | -451.874% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | -189.165% |
| Bioventus Inc. | -81.72 Million USD | -91.165% |
| BrainsWay Ltd. | -4.92 Million USD | -3070.895% |
| Envoy Medical, Inc. | -18.37 Million USD | -750.416% |
| electroCore, Inc. | -18.8 Million USD | -730.79% |
| IceCure Medical Ltd | -15.57 Million USD | -903.017% |
| Lucid Diagnostics Inc. | -48.48 Million USD | -222.243% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | -804.736% |
| MaxCyte, Inc. | -48.29 Million USD | -223.464% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | -1206.79% |
| Nexalin Technology, Inc. | -5.69 Million USD | -2642.659% |
| PAVmed Inc | -68.79 Million USD | -127.095% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | -176.205% |
| RxSight, Inc. | -50.08 Million USD | -211.93% |
| Sight Sciences, Inc. | -57.27 Million USD | -172.776% |
| SI-BONE, Inc. | -46.93 Million USD | -232.893% |
| TELA Bio, Inc. | -44.07 Million USD | -254.464% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | -188.513% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | -203.784% |
| LivaNova PLC | -68.49 Million USD | -128.08% |
| 908 Devices Inc. | -42.75 Million USD | -265.382% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 9.899% |
| Nemaura Medical Inc. | -9.59 Million USD | -1528.204% |
| NeuroPace, Inc. | -27.17 Million USD | -474.925% |
| LENSAR, Inc. | -12.22 Million USD | -1177.537% |
| Apyx Medical Corporation | -17.25 Million USD | -805.209% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | -1715.783% |
| BioSig Technologies, Inc. | -28.51 Million USD | -447.945% |
| Anika Therapeutics, Inc. | -87.63 Million USD | -78.265% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | -596.026% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 240.084% |
| Axonics, Inc. | -26.05 Million USD | -499.57% |
| Outset Medical, Inc. | -169.77 Million USD | 7.975% |
| IRIDEX Corporation | -10 Million USD | -1461.207% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | -43.107% |
| IRadimed Corporation | 20.03 Million USD | 879.768% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -1794.846% |
| INVO Bioscience, Inc. | -6.76 Million USD | -2208.651% |
| Telesis Bio, Inc. | -35.15 Million USD | -344.467% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 1190.23% |
| Varex Imaging Corporation | 32.1 Million USD | 586.698% |
| Quipt Home Medical Corp. | 3.91 Million USD | 4086.476% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -1187.645% |
| Pulmonx Corporation | -61.93 Million USD | -152.248% |
| Dynatronics Corporation | -2.27 Million USD | -6773.15% |
| Modular Medical, Inc. | -17.52 Million USD | -791.266% |
| ReShape Lifesciences Inc. | -14.63 Million USD | -967.218% |
| Semler Scientific, Inc. | 22.25 Million USD | 801.968% |
| InMode Ltd. | 195.66 Million USD | 179.848% |
| Bruker Corporation | 436.9 Million USD | 135.759% |
| Cytosorbents Corporation | -31.2 Million USD | -400.589% |
| DexCom, Inc. | 597.7 Million USD | 126.139% |
| Align Technology, Inc. | 643.33 Million USD | 124.284% |
| Viveve Medical, Inc. | -21.55 Million USD | -624.864% |
| ZimVie Inc. | -30.93 Million USD | -404.961% |
| Movano Inc. | -29.69 Million USD | -426.204% |
| Cytek Biosciences, Inc. | -27.84 Million USD | -461.07% |
| Nexalin Technology, Inc. | -5.69 Million USD | -2642.659% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -4328.288% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 33.015% |
| Profound Medical Corp. | -28.61 Million USD | -445.953% |
| Insulet Corporation | 220 Million USD | 171.014% |
| enVVeno Medical Corporation | -25.23 Million USD | -519.027% |
| Surmodics, Inc. | -5.64 Million USD | -2667.582% |
| iCAD, Inc. | -7.68 Million USD | -1931.864% |
| Nuwellis, Inc. | -17.63 Million USD | -786.16% |
| Biotricity, Inc. | -8.82 Million USD | -1669.656% |
| iRhythm Technologies, Inc. | -125.16 Million USD | -24.823% |
| Aethlon Medical, Inc. | -12.63 Million USD | -1136.333% |
| InspireMD, Inc. | -21.14 Million USD | -638.921% |
| PAVmed Inc. | -68.79 Million USD | -127.095% |
| BIOLASE, Inc. | -17.93 Million USD | -770.993% |
| Beyond Air, Inc. | -63 Million USD | -147.961% |
| FONAR Corporation | 16.53 Million USD | 1044.823% |
| AxoGen, Inc. | -21.46 Million USD | -627.938% |
| Vivani Medical, Inc. | -26.96 Million USD | -479.381% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 965.972% |
| Inari Medical, Inc. | -14.03 Million USD | -1013.384% |
| UFP Technologies, Inc. | 57.66 Million USD | 370.932% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -3070.509% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -2377.572% |
| Tenon Medical, Inc. | -15.72 Million USD | -893.387% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -1990.313% |
| Co-Diagnostics, Inc. | -42.7 Million USD | -265.825% |
| AdaptHealth Corp. | -598.4 Million USD | 73.892% |
| Sintx Technologies, Inc. | -13.35 Million USD | -1069.561% |
| NanoVibronix, Inc. | -3.43 Million USD | -4446.857% |
| Quanterix Corporation | -49.7 Million USD | -214.34% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -1187.645% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -40797.906% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 53.29% |
| TransMedics Group, Inc. | -28.72 Million USD | -443.844% |
| ReWalk Robotics Ltd. | -23.61 Million USD | -561.655% |
| NeuroMetrix, Inc. | -7.15 Million USD | -2084.57% |
| Hyperfine, Inc. | -48.11 Million USD | -224.701% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | -140.258% |
| Biomerica, Inc. | -6.36 Million USD | -2353.746% |
| Bone Biologics Corporation | -9.42 Million USD | -1557.032% |
| AVITA Medical, Inc. | -40.4 Million USD | -286.688% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | -1415.146% |
| Silk Road Medical, Inc | -59.27 Million USD | -163.586% |